Efficacy and Safety of Intermittent Repeated Levosimendan Infusions in Advanced Heart Failure Patients: The LAICA Study

Figure 1. Study flow chart.

Figure 2. Cumulative incidence of (A) hospital admission for acute decompensated heart failure (HF) or HF worsening; and (B) hospital admission for acute decompensated HF or HF worsening and death.

Figure 3. Kaplan–Meier survival probability for (A) time from randomization to first hospitalization for acute decompensated heart failure (HF); and (B) time from randomization to death.

Figure 4. Cumulative incidence of death.

Figure 5. Improvement of New York Heart Association (NYHA) scale throughout the study: column results are expressed as frequencies (percentages).